24 May 2013
Keywords: Boehringer Ingelheim, Eli Lilly, Jentadueto, EU approval
Article | 26 July 2012
Independent German drug major Boehringer Ingelheim and US partner Eli Lilly (NYSE: LLY) received Marketing Authorisation from the European Commission ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 July 2012
25 July 2012
23 May 2013
© 2013 thepharmaletter.com